Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients

被引：8

作者：

Moldovan, Diana ^{[1
]}

Kacso, Ina Maria ^{[1
]}

Rusu, Crina ^{[1
]}

Potra, Alina ^{[1
]}

Bondor, Cosmina Ioana ^{[2
]}

Moldovan, Ioan ^{[3
]}

Patiu, Ioan Mihai ^{[4
]}

Vladutiu, Dan ^{[1
]}

Caprioara, Mirela Gherman ^{[1
]}

机构：

[1] Univ Med & Pharm Iuliu Hatieganu, Dept Nephrol, Cluj Napoca, Romania

[2] Univ Med & Pharm Iuliu Hatieganu, Dept Stat, Cluj Napoca, Romania

[3] Emergency Mil Hosp, Cluj Napoca, Romania

[4] Nefromed Dialysis Ctr, Cluj Napoca, Romania

来源：

BIOMARKERS | 2015年 / 20卷 / 02期

关键词：

Cardiovascular disease; immunotoxicity; renal disease; CHRONIC KIDNEY-DISEASE; INTIMA-MEDIA THICKNESS; SERUM OSTEOPROTEGERIN; CARDIOVASCULAR EVENTS; FETUIN-A; ELEVATED OSTEOPROTEGERIN; CALCIFICATION INHIBITORS; PLASMA OSTEOPROTEGERIN; HEMODIALYSIS; ARTERY;

D O I：

10.3109/1354750X.2014.1000376

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To assess the osteoprotegerin (OPG) relationship with cardiovascular complications in hemodialysis (HD) patients. Methods: The study included 87 HD patients. Clinical characteristics, ankle-arm index (AAI), OPG and mineral markers levels were recorded. Arterial intimal calcification (AIC) and arterial medial calcification (AMC) were registered. Results: OPG levels were increased in HD patients. Patients with AIC (p = 0.006)/ AMC (p = 0.01) had higher OPG levels. OPG did not have any relation with cardiovascular diseases. OPG correlated positively with age, increased HD vintage and inversely with albumin and AAI. OPG has not been a risk factor for VC or cardiovascular disease. Conclusion: OPG rising could be a reaction in defense to vascular aggression, because OPG was associated with VC, but not with vascular disease.

引用

页码：116 / 122

页数：7

共 50 条

[1] Vascular calcification in patients with end-stage renal disease
Floege, J
Ketteler, M
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 : 59 - 66
[2] Vascular Calcification in End-Stage Renal Disease Patients
Nitta, Kosaku
Ogawa, Tetsuya
CHRONIC KIDNEY DISEASES - RECENT ADVANCES IN CLINICAL AND BASIC RESEARCH, 2015, 185 : 156 - 167
[3] PSYCHIATRIC DISORDERS IN PATIENTS WITH END-STAGE RENAL DISEASE
Martiny, Camila
de Oliveira e Silva, Adriana Cardoso
Simoes Neto, Jose Pedro
Nardi, Antonio Egidio
JOURNAL OF RENAL CARE, 2012, 38 (03) : 131 - 137
[4] Peripheral vascular disease in end-stage renal disease patients
O'Hare, AM
Johansen, KL
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2002, 25 (12): : 1123 - 1127
[5] Vascular access in elderly patients with end-stage renal disease
Bessias, Nikolaos
Paraskevas, Kosmas I.
Tziviskou, Effie
Andrikopoulos, Vassilios
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (04) : 1133 - 1142
[6] Vascular access in elderly patients with end-stage renal disease
Nikolaos Bessias
Kosmas I. Paraskevas
Effie Tziviskou
Vassilios Andrikopoulos
International Urology and Nephrology, 2008, 40 : 1133 - 1142
[7] PREDICTORS OF VASCULAR CALCIFICATION IN END-STAGE RENAL DISEASE PATIENTS
Dai, Lu
Debowska, Malgorzata
Lukaszuk, Tomasz
Bobrowski, Leon
Pietribiasi, Mauro
Barany, Peter
Soderberg, Magnus
Wernerson, Annika
Lindholm, Bengt
Qureshi, Abdul Rashid
Waniewski, Jacek
Stenvinkel, Peter
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 165 - 165
[8] End-stage renal disease (ESRD) in patients with eating disorders
AbdelRahman, EM
Moorthy, AV
CLINICAL NEPHROLOGY, 1997, 47 (02) : 106 - 111
[9] Breathing and movement disorders in patients with end-stage renal disease
Sanner, BM
Schulte-Vorwick, M
Randerath, W
Zidek, W
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A564 - A564
[10] Vascular calcification in end-stage renal disease
Goodman, WG
JOURNAL OF NEPHROLOGY, 2002, 15 : S82 - S85

← 1 2 3 4 5 →